Long-term tocolysis with intravenous magnesium sulfate

Area of Science:

• Obstetrics and Gynecology
• Pharmacology

Background:

• Magnesium sulfate is a known tocolytic agent.
• Its use in tocolysis has historically been limited to short durations.

Purpose of the Study:

• To evaluate the safety and efficacy of prolonged intravenous magnesium sulfate administration for tocolysis.
• To determine if extended use of magnesium sulfate impacts complication rates.

Main Methods:

• A retrospective study of 111 women receiving intravenous magnesium sulfate for tocolysis.
• Patients were categorized into short-term (≤3 days), intermediate (3-10 days), and long-term (>10 days) treatment groups.
• Adverse events and reasons for discontinuation were recorded.

Main Results:

• Side effects like ileus, constipation, visual blurring, and headache were more frequent in intermediate and long-term groups.
• No life-threatening complications were observed across all groups.
• Discontinuation due to side effects occurred in 7% of patients in each group.

Conclusions:

• Prolonged magnesium sulfate tocolysis is feasible and does not appear to be associated with life-threatening complications.
• Clinical indication, rather than a predetermined time limit, should guide the duration of magnesium sulfate therapy.
• Further research may explore optimal dosing and monitoring for extended use.